活化凝血因子Xa通过促进RPE上皮间质转化参与外伤性PVR发生
本研究评估凝血因子Xa(FXa)在视网膜色素上皮(RPE)细胞及小鼠增生性玻璃体视网膜病变(PVR)模型中的促纤维化作用。外伤性PVR患者及兔机械性眼外伤后玻璃体FXa升高,FXa可诱导RPE上皮间质转化(EMT),与dispase共注射加重小鼠眼内纤维化。口服FXa或凝血酶抑制剂可显著阻断PVR小鼠模型眼内纤维化,机制涉及PAR1依赖的p38磷酸化活化及TGF-βR信号。
要点
- 外伤性PVR患者玻璃体FXa水平高于黄斑裂孔患者,且视网膜前膜表达FXa与PAR1。
- FXa通过PAR1依赖的p38磷酸化活化诱导RPE发生EMT。
- 口服FXa或凝血酶抑制剂可显著阻断PVR小鼠模型眼内纤维化。
核心结论
- FXa通过涉及RPE活化的机制促进小鼠眼内纤维化。
- FXa在RPE细胞中诱导EMT,表现为ZO-1破坏、细胞极性受损及纤连蛋白表达增加。
- 口服FXa或凝血酶抑制剂可显著阻断PVR小鼠模型眼内纤维化。
研究设计与样本
- 检测外伤性PVR患者及兔机械性眼外伤模型眼中FXa水平(ELISA和免疫组化)。
- 体外评估FXa诱导的RPE EMT(细胞增殖、迁移、紧密连接变化及纤维化标志物表达)。
- 小鼠眼内注射FXa至dispase损伤眼,组织学分析和Western blotting评估眼内纤维化。
- 在PVR小鼠模型中检测FXa抑制剂的治疗效应。
主要发现
- 外伤性PVR患者玻璃体FXa高于黄斑裂孔患者,且其视网膜前膜表达FXa和PAR1。
- 兔机械性眼外伤后玻璃体FXa明显升高。
- FXa刺激RPE EMT,表现为ZO-1破坏、细胞极性受损和纤连蛋白表达增加。
- 小鼠共注射FXa与dispase较单用FXa或dispase引起更严重视网膜结构损伤和α-SMA表达增加。
- FXa通过PAR1依赖方式促进ARPE19细胞p38磷酸化活化,TGF-βR抑制剂显著减轻FXa诱导的小鼠眼内纤维化。
临床怎么用
- FXa可能作为外伤性PVR的潜在治疗靶点,FXa或凝血酶抑制剂在动物模型中显示抗纤维化效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Uncontrolled coagulation reactions contribute to pathological fibroproliferation in several organs, and yet their role in proliferative vitreoretinopathy (PVR) remains to be elucidated. In this study, we evaluated the profibrotic effects of FXa in RPE cells and in a mouse model of PVR. METHODS: FXa levels in the eyes of traumatic PVR patients and rabbit models of mechanical ocular trauma was measured by ELISA and immunohistochemistry. FXa-induced RPE EMT was assessed by examining cell proliferation, migration, tight junction changes, and expression of fibrotic markers. For in vivo study, FXa was injected into dispase-injured eyes, then intraocular fibrosis was evaluated by histological analysis and Western blotting. The therapeutic effect of FXa inhibitor was also examined in PVR mouse models. RESULTS: Vitreous FXa were higher in patients with traumatic PVR compared to patients with macular hole. Moreover, expressions of FXa and PAR1 were found in the epiretinal membranes from traumatic PVR patients. Vitreous FXa were markedly increased after mechanical ocular trauma in rabbits. In vitro, FXa stimulated RPE EMT characterized as ZO-1 disruption, compromised cell polarity, and increased fibronectin expressions. Co-injection of FXa and dispase in mice induced more severely damaged retinal structures, and increased α-SMA expressions than FXa or dispase treatment alone. Oral FXa or thrombin inhibitors significantly blocked intraocular fibrosis in PVR mouse models. FXa promoted phospho-activation of p38 in ARPE19 cells, which was dependent on PAR1. Moreover, TGF-βR inhibitor also significantly alleviated FXa-induced intraocular fibrosis in mice. CONCLUSIONS: FXa promotes intraocular fibrosis in mice via mechanisms involving RPE activation.
引用
- Han H, Zhao X, Liao M, et al. Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition. Invest Ophthalmol Vis Sci. 2021. PMID: 34283209. doi:10.1167/iovs.62.9.29
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。